Erin Parsons's most recent trade in Kiora Pharmaceuticals Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharmaceuticals Inc | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,778 | 1,778 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Erin Parsons | Director | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 13 Jun 2024 | 5,260 | 5,260 (0%) | 0% | 4.9 | 25,669 | Common Stock |
| Kiora Pharmaceuticals Inc | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Alimera Sciences Inc. | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 6,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
| Kiora Pharmaceuticals Inc | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 4,000 | 4,000 | - | - | Stock Option (right to buy) | |
| Alimera Sciences Inc. | Erin Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 3,255 | 3,255 | - | - | Stock Option (Right to Buy) |